Ep. 24: Reimagining clinical research as new capabilities come to market

The Latest Dose

Content provided by Kathy Vandebelt and Oracle Corporation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Kathy Vandebelt and Oracle Corporation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2+ y ago 46:01

MP3•Episode home

Life sciences organizations face intense pressure to speed clinical trials while boosting operational efficiencies to battle the rising costs of drug development. So what does the future of clinical trials look like?

In this episode, Dr. Avi Kulkarni, senior vice president of research and development at Cognizant, and Henry McNamara, senior vice president and GM of Oracle Health Sciences, share their views on what has been accomplished over the past 10 years, current trends, and their outlook for the future.

43 episodes

#Tech #Kathy Vandebelt #Biotech #Adverseevents #Artificialintelligence #Bigdata #Biometricmonitoring #Biotechnology #Biotechnologycompanies #Caseprocessing #Clinicaldata #Clinicalresearch #Clinicalsites #Clinicaltechnology #Clinicaltrialdata #Clinicaltrials #Contractresearchorganizations #Decentralizedclinicaltrials #Decentralizedtrials #Drugdevelopment #Drugresearch #Drugsafety #Eclinical #Eclinicaltechnology #Healthsciences #Healthtechnology #Medicaldevices #Medicine #Multivigilance #Oraclehealthsciences #Patientcentric #Pharmaceuticalcompanies #Pharmaceuticalresearch #Pharmacovigilance #Remotemonitoring #Remotevisits #Safetyai #Safetyartificialintelligence #Oracle #Oraclecloud #Oraclelifesciences #Oracle Corporation #Touchlesscaseprocessing #Podcasting Education #CRO #Doctor Who #Hospitality #LifeSciences #Patient #Pharmaceutical